Artwork

内容由Lynn Marie Morski, MD, and JD提供。所有播客内容(包括剧集、图形和播客描述)均由 Lynn Marie Morski, MD, and JD 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Psilocybin for Obsessive-Compulsive Disorder (OCD) with Sorcha O'Connor, PhD(c)

35:33
 
分享
 

Manage episode 460196743 series 3468391
内容由Lynn Marie Morski, MD, and JD提供。所有播客内容(包括剧集、图形和播客描述)均由 Lynn Marie Morski, MD, and JD 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this episode, Sorcha O'Connor, PhD(c) joins to discuss the research into the use of psilocybin to address obsessive-compulsive disorder (OCD). Sorcha is completing her neuroscience PhD at Imperial College London, specialising in mental health research. She led PsilOCD, a pioneering study investigating low-dose psilocybin as a treatment for both the clinical symptoms and cognitive features of OCD.

In this conversation, Sorcha introduces obsessive-compulsive disorder and discusses the ways medical professionals are currently thinking about this and other related conditions. She mentions that current therapies for OCD often only minimally improve symptoms, emphasizing the need for better treatment options. This led to studies exploring psilocybin as a treatment for OCD - and Sorcha emphasizes that the early trials have shown positive results, often with significant decreases in OCD symptoms. In conclusion, Sorcha discusses the protocol for the PsilOCD study at Imperial College London, with results from this study soon to be published.

In this episode you'll hear:

  • The features of obsessive-compulsive disorder (OCD)
  • The history and development of treatments for OCD
  • The theory behind the hypothesis that psilocybin may be effective for OCD
  • Trials exploring the efficacy of psychedelic treatments for OCD
  • Why psilocybin has come to the fore more than LSD or ketamine for prospective OCD studies
  • How patients are evaluated for OCD

Quotes:

“[OCD] is this complex behavioral pattern and certain medications moderately help and nothing seems to be highly effective yet and that definitely points to the need for novel pharmacotherapy.” [12:46]

“[By utilizing lower doses of psilocybin], people who maybe fixate on their health and on their mental health and sensations and things can benefit from psilocybin without having to overcome that barrier.” [18:25]

Links:

Sorcha on LinkedIn

PsilOCD Study details on the Imperial College London website

Dr. Michael J. Greenberg’s website

Psychedelic Medicine Association

Porangui

  continue reading

169集单集

Artwork
icon分享
 
Manage episode 460196743 series 3468391
内容由Lynn Marie Morski, MD, and JD提供。所有播客内容(包括剧集、图形和播客描述)均由 Lynn Marie Morski, MD, and JD 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this episode, Sorcha O'Connor, PhD(c) joins to discuss the research into the use of psilocybin to address obsessive-compulsive disorder (OCD). Sorcha is completing her neuroscience PhD at Imperial College London, specialising in mental health research. She led PsilOCD, a pioneering study investigating low-dose psilocybin as a treatment for both the clinical symptoms and cognitive features of OCD.

In this conversation, Sorcha introduces obsessive-compulsive disorder and discusses the ways medical professionals are currently thinking about this and other related conditions. She mentions that current therapies for OCD often only minimally improve symptoms, emphasizing the need for better treatment options. This led to studies exploring psilocybin as a treatment for OCD - and Sorcha emphasizes that the early trials have shown positive results, often with significant decreases in OCD symptoms. In conclusion, Sorcha discusses the protocol for the PsilOCD study at Imperial College London, with results from this study soon to be published.

In this episode you'll hear:

  • The features of obsessive-compulsive disorder (OCD)
  • The history and development of treatments for OCD
  • The theory behind the hypothesis that psilocybin may be effective for OCD
  • Trials exploring the efficacy of psychedelic treatments for OCD
  • Why psilocybin has come to the fore more than LSD or ketamine for prospective OCD studies
  • How patients are evaluated for OCD

Quotes:

“[OCD] is this complex behavioral pattern and certain medications moderately help and nothing seems to be highly effective yet and that definitely points to the need for novel pharmacotherapy.” [12:46]

“[By utilizing lower doses of psilocybin], people who maybe fixate on their health and on their mental health and sensations and things can benefit from psilocybin without having to overcome that barrier.” [18:25]

Links:

Sorcha on LinkedIn

PsilOCD Study details on the Imperial College London website

Dr. Michael J. Greenberg’s website

Psychedelic Medicine Association

Porangui

  continue reading

169集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南

边探索边听这个节目
播放